Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Remdesivir 100mg|
|Dosage Form:||Powder for injection|
|New Zealand Sponsor:||Gilead Sciences (NZ)|
|Manufacturers:||Patheon Manufacturing Services LLC, North Carolina, United States of America
Hikma Farmaceutica (Portugal) Lda, Terrugem, Portugal
Jubilant HollisterStier LLC, Washington, United States of America
Patheon Italia S.p.A, Milan, Italy
Dated this 14th day of September 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).